# Mr. Anshul Gupta, Resolution Professional of Arch Pharmalabs Limited vs. Arch Pharmalabs Limited

> NCLT judgment dated 2026-10-15. Citation: TCN-2026-NCLT-01225. IA (IBC) (Plan) No. 127/MB/2025 was filed by Mr. Anshul Gupta, the Resolution Professional (RP)…

- **Court:** NCLT
- **Order date:** 15 Oct 2026
- **Citation:** TCN-2026-NCLT-01225
- **Category:** IBC
- **Source page:** https://caseease.in/cases/ibc/nclt-mumbai/approval-of-resolution-plan-arch-pharmalabs-limited-9nan1

## Summary

### Background

IA (IBC) (Plan) No. 127/MB/2025 was filed by Mr. Anshul Gupta, the Resolution Professional (RP) of Arch Pharmalabs Limited (Corporate Debtor), seeking approval of the Resolution Plan dated 30.09.2025. The Corporate Debtor was admitted into Corporate Insolvency Resolution Process (CIRP) on 15.05.2024, initiated by ICICI Bank Limited as Financial Creditor. Mr. Sanjay Garg was initially appointed Interim Resolution Professional (IRP) but was later replaced by Mr. Anshul Gupta. The Resolution Plan was submitted by a consortium of Mr. Ashish Kumar and MetaX Life Sciences Limited (Successful Resolution Applicant - SRA) and received 98.03% approval from the Committee of Creditors (CoC) on 01.10.2025, with e-voting concluded on 24.10.2025. The SRA furnished a Performance Bank

…

## Facts

IA (IBC) (Plan) No. 127/MB/2025 was filed on 10.11.2025 by Mr. Anshul Gupta, Resolution Professional of Arch Pharmalabs Limited.

The application seeks approval of the Resolution Plan dated 30.09.2025.

Arch Pharmalabs Limited (Corporate Debtor) was admitted into CIRP on 15.05.2024 in C.P.(IB) No.686/MB/2023.

ICICI Bank Limited was the Financial Creditor who initiated the CIRP.

Mr. Sanjay Garg was initially appointed Interim Resolution Professional (IRP).

Mr. Sanjay Garg was replaced by Mr. Anshul Gupta as Resolution Professional (RP) during the first CoC meeting on 10.02.2025, confirmed by Tribunal order on 27.02.2025.

The RP published an invitation for expression of interest (IEOI) on 16.03.2025, which was amended on 27.03.2025.

…

## Issues and analysis

### Issue 1: Whether the Resolution Plan submitted by the consortium of Mr. Ashish Kumar and MetaX Life Sciences …

**Ratio:** The Resolution Plan must comply with Section 30(2) of the IBC and Regulations 37, 38,

…

**Reasoning:** The CoC considered the feasibility and viability of the Plan and approved it with 100%

…

**Interpretation:** Compliance with Section 30(2) and relevant regulations ensures the plan is

…

**Application:** The NCLT found that the Plan meets these requirements and is not in

…

## Parties

- **Judges:** ASHISH KALIA,…; ANIL RAJ CHELLAN,…
- **Appellants:** Anshul Gupta,…; Anshul…; +1 more
- **Respondents:** Arch Pharmalabs…
- **Other parties:** Committee of…; suspended…; +15 more
- **Advocates:** Ashish…; Saloni Ka…; +2 more

## Timeline

- **1993-04-02 — Corporate Debtor…**: Arch Pharmalabs Limited…
- **2000-10-17 — MetaX Incorp…**: MetaX Life Sciences…

## Legal provisions

- [Insolvency and Bankruptcy Code, 2016, Section 30(6) — Submission of resolution plan](https://caseease.in/legal-provisions/insolvency-and-bankruptcy-code-2016/section-30)

---

This is a preview. The full structured summary, issues, precedents and source judgment are available on CaseEase - Legal Intelligence Simplified: https://caseease.in/cases/ibc/nclt-mumbai/approval-of-resolution-plan-arch-pharmalabs-limited-9nan1